跳至主要内容
临床试验/CTRI/2015/10/006325
CTRI/2015/10/006325尚未招募未知

A randomized controlled study to evaluate autologous platelet rich plasma as an ideal substance for submucosal injection during endoscopic mucosal resection

Andhra Medical College0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with sessile gastrointestinal polyps of diameter 1mm to 20mm diagnosed by Upper gastrointestinal endoscopy or colonoscopy will be included for the study.
  • 2. If multiple polyps are present, only the largest sessile polyp (but less than or equal to 20 mm diameter) will be considered for the study.

排除标准

  • 1. Age less than 20 years and age greater than 80 years
  • 2. Pedunculated polyps
  • 3. Sessile polyps less than 1 mm or greater than 20 mm in diameter
  • 4. Lesions with ulceration
  • 5.Friability
  • 6. Non- lifting sign or lesions demonstrating deep submucosal invasion
  • 7. Residual or recurrent lesion
  • 8. Diagnosed case of inflammatory bowel disease
  • 9. Coagulopathies
  • 10. Cardiac pacemaker
  • 11. Pregnant or lactating females
  • 12. Patients who are on anti-coagulant drugs and anti-platelet drugs
  • 13. Routine contraindications for gastrointestinal endoscopy

研究者

相似试验